Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Jito (JTO) vs Enzyme (MLN) Price & Performance

Price performance (Past 24H)

Key statistics

Jito vs Enzyme — how do they compare? Jito trades at Rp9,696 (market cap Rp4,9T, Rp368,61M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Jito is far larger — about 36531.7× Enzyme's market cap, and Jito's circulating supply is 509,8M JTO versus 3,3M MLN for Enzyme. Which is the better fit depends on your goals — on Pluang, investors hold Jito for 29 Days and Enzyme for 29 Days on average.

JTOMLN
Market Cap
Rp4,9TRp134,13M
Volume (24h)
Rp368,61MRp104,56M
Circulating Supply
509,8M JTO3,3M MLN
Typical Hold Time
29 Days29 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Jito

Jito is trading at Rp10,083 with a market cap of Rp5.14T, showing a bullish technical signal driven by moving averages. The current price is near the pivot point of Rp10,059, with support at Rp9,673 and resistance at Rp10,286. RSI_6 indicates overbought conditions at 92.32, while ADX signals a strong trend. No major protocol updates or ecosystem news were found recently.

Overall outlook is cautiously optimistic due to bullish technicals, but high RSI suggests potential pullback. Key opportunities include strong trend momentum; major risks involve overbought volatility and lack of recent fundamental catalysts. Investors should monitor support levels for entry points.

Enzyme

Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.

Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

JTO
79% Buy21% Sell
Avg holding period · 29 Days
MLN

No sentiment data available yet.

Top news

Latest headlines on both assets

About Jito

Jito Network is a major contributor to the Solana ecosystem through its JitoSOL liquid staking pool, and its collection of MEV products. With Jito, users can stake their SOL tokens through the Jito Stake Pool, receiving the JitoSOL token, which is a unique asset that not only provides liquidity but also combines staking rewards and MEV rewards.

Read more on JTO

About Enzyme

Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.

Read more on MLN